Dr. Christopher Scheiner, MD

NPI: 1487864773
Total Payments
$208,270
2024 Payments
$147,144
Companies
50
Transactions
512
Medicare Patients
1,199
Medicare Billing
$120,726

Payment Breakdown by Category

Other$123,358 (59.2%)
Travel$46,800 (22.5%)
Consulting$25,690 (12.3%)
Food & Beverage$12,381 (5.9%)
Education$42.08 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $122,803 46 59.0%
Travel and Lodging $46,800 106 22.5%
Consulting Fee $25,690 9 12.3%
Food and Beverage $12,381 346 5.9%
Honoraria $555.00 1 0.3%
Education $42.08 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $112,532 125 $0 (2024)
CSL Behring $86,769 225 $0 (2024)
ARGENX US, INC. $4,185 20 $0 (2024)
UCB, Inc. $1,960 18 $0 (2024)
Biogen, Inc. $257.16 10 $0 (2024)
Janssen Scientific Affairs, LLC $173.42 3 $0 (2024)
Akcea Therapeutics, Inc. $156.15 1 $0 (2019)
Biohaven Pharmaceuticals, Inc. $145.28 6 $0 (2021)
Allergan, Inc. $136.71 9 $0 (2022)
GENZYME CORPORATION $116.70 5 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $147,144 230 Alexion Pharmaceuticals, Inc. ($90,269)
2023 $34,788 134 CSL Behring ($22,814)
2022 $24,456 86 Alexion Pharmaceuticals, Inc. ($12,429)
2021 $1,324 42 CSL Behring ($725.75)
2020 $223.36 13 Allergan, Inc. ($30.65)
2019 $336.29 7 Akcea Therapeutics, Inc. ($156.15)

All Payment Transactions

512 individual payment records from CMS Open Payments — Page 1 of 21

Date Company Product Nature Form Amount Type
12/20/2024 CSL Behring Hizentra (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,145.00 General
Category: Immunology
12/20/2024 CSL Behring Hizentra (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,145.00 General
Category: Immunology
12/17/2024 Vanda Pharmaceuticals Inc. PONVORY (Drug) Food and Beverage In-kind items and services $13.76 General
Category: MULTIPLE SCLEROSIS
12/13/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $21.82 General
Category: Rare Disease
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging In-kind items and services $825.70 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging In-kind items and services $602.95 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging In-kind items and services $136.85 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $94.50 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $32.00 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $24.43 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $24.28 General
Category: Immunology
12/12/2024 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $18.27 General
Category: Immunology
12/09/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $12,862.50 General
Category: Rare Disease
12/09/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Travel and Lodging In-kind items and services $427.98 General
Category: Rare Disease
12/09/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $304.18 General
Category: Immunology
12/09/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $37.00 General
Category: Immunology
12/09/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Travel and Lodging Cash or cash equivalent $23.93 General
Category: Rare Disease
12/09/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Travel and Lodging Cash or cash equivalent $21.55 General
Category: Rare Disease
12/09/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $19.78 General
Category: Immunology
12/09/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $19.62 General
Category: Immunology
12/09/2024 Lilly USA, LLC EMGALITY (Drug), AMYVID, REYVOW Food and Beverage In-kind items and services $19.57 General
Category: Neuroscience
12/09/2024 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $14.38 General
Category: Immunology
12/09/2024 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $3.61 General
Category: Immunology
12/06/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $26.90 General
Category: Immunology
12/06/2024 CSL Behring Hizentra (Biological) Travel and Lodging Cash or cash equivalent $24.26 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 374 455 $154,818 $37,723
2022 7 200 226 $51,346 $14,005
2021 11 333 438 $111,001 $32,054
2020 11 292 344 $100,428 $36,944
Total Patients
1,199
Total Services
1,463
Medicare Billing
$120,726
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 45 67 $28,155 $7,644 27.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 59 88 $26,510 $7,404 27.9%
95910 Nerve conduction, 7-8 studies Office 2023 50 51 $19,110 $4,692 24.6%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 83 105 $21,173 $4,490 21.2%
95913 Nerve conduction, 13 or more studies Office 2023 25 25 $16,465 $3,343 20.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 24 24 $12,480 $3,318 26.6%
95912 Nerve conduction, 11-12 studies Office 2023 21 21 $11,280 $2,892 25.6%
95911 Nerve conduction, 9-10 studies Office 2023 24 24 $11,775 $2,448 20.8%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2023 32 38 $5,070 $849.90 16.8%
95908 Nerve conduction, 3-4 studies Office 2023 11 12 $2,800 $644.23 23.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 36 46 $8,970 $2,962 33.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 21 24 $6,360 $2,724 42.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 25 25 $5,095 $1,798 35.3%
95910 Nerve conduction, 7-8 studies Office 2022 19 19 $7,805 $1,547 19.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 11 11 $3,075 $1,219 39.6%
95911 Nerve conduction, 9-10 studies Office 2022 12 12 $6,180 $1,085 17.6%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 28 34 $5,911 $1,075 18.2%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2022 18 21 $3,675 $733.29 20.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 13 $1,755 $616.96 35.2%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2022 17 21 $2,520 $244.38 9.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 44 77 $20,405 $8,341 40.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 45 78 $15,210 $5,889 38.7%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 33 33 $12,375 $4,518 36.5%
95913 Nerve transmission studies, 13 or more studies Office 2021 25 26 $18,980 $3,797 20.0%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 62 78 $13,416 $2,841 21.2%

About Dr. Christopher Scheiner, MD

Dr. Christopher Scheiner, MD is a Neurology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487864773.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Scheiner, MD has received a total of $208,270 in payments from pharmaceutical and medical device companies, with $147,144 received in 2024. These payments were reported across 512 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($122,803).

As a Medicare-enrolled provider, Scheiner has provided services to 1,199 Medicare beneficiaries, totaling 1,463 services with total Medicare billing of $120,726. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Dayton, OH
  • Active Since 05/23/2007
  • Last Updated 01/20/2015
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1487864773

Products in Payments

  • Hizentra (Biological) $86,714
  • ULTOMIRIS (Biological) $82,652
  • VYVGART (Drug) $3,925
  • SOLIRIS (Biological) $3,450
  • Zilbrysq (Biological) $1,260
  • VYVGART HYTRULO (Drug) $225.92
  • NURTEC ODT (Drug) $209.88
  • BOTOX (Biological) $187.62
  • ZEPOSIA (Drug) $172.62
  • Soliris (Drug) $157.24
  • TEGSEDI (Drug) $156.15
  • Rystiggo (Drug) $146.05
  • Briviact (Drug) $131.33
  • SOLIRIS (Drug) $128.65
  • Fintepla (Drug) $98.08
  • VALTOCO (Drug) $93.86
  • Nayzilam (Drug) $86.00
  • Spinraza (Biological) $86.00
  • KESIMPTA (Drug) $85.64
  • SPINRAZA (Biological) $78.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Dayton